Skip to main content
65°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
116.60
+0.05 (+0.04%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Market Analysis: Merck & Co And Competitors In Pharmaceuticals Industry
May 07, 2024
Via
Benzinga
3 Biotech Stocks to Double Your Money in the Next 24 Months
May 06, 2024
The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.
Via
InvestorPlace
In a market where value is scarce, NYSE:MRK offers a refreshing opportunity with its solid fundamentals.
May 06, 2024
MERCK & CO. INC. (NYSE:MRK) stands out as a stock that provides good value for the fundamentals it showcases.
Via
Chartmill
Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy
May 03, 2024
Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expand BCG supply. FDA-approved Anktiva plus BCG for bladder cancer.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 02, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Understanding Merck & Co's Position In Pharmaceuticals Industry Compared To Competitors
April 23, 2024
Via
Benzinga
Looking Into Merck & Co's Recent Short Interest
April 23, 2024
Via
Benzinga
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
May 02, 2024
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouraging data from its Phase III gastric cancer treatment trial after...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
May 01, 2024
From
Merck & Co., Inc.
Via
Business Wire
Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
April 29, 2024
From
Merck & Co., Inc.
Via
Business Wire
3 Under-The-Radar Stocks With Positive Potential
April 21, 2024
Via
Talk Markets
Unveiling 17 Analyst Insights On Merck & Co
April 18, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRK Options
April 17, 2024
Via
Benzinga
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
April 28, 2024
The first-quarter 2024 earnings season picked up pace this week, with Merck, Sanofi, Novartis, and AstraZeneca announcing their first-quarter results. Three of the four companies beat estimates for...
Via
Talk Markets
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
April 26, 2024
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Via
Investor's Business Daily
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
April 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Merck (MRK) Q1 2024 Earnings Call Transcript
April 25, 2024
MRK earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
April 25, 2024
Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NASDAQ:META) are being compounded by weaker-than-expected economic growth...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
April 25, 2024
Merck reported Q1 sales of $15.8 billion, beating estimates, with cancer drug Keytruda driving growth. Company raised full-year revenue and EPS forecasts.
Via
Benzinga
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
April 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
MRK stock results show that Merck & Co beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings – Here Is The Real Reason
April 25, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
Merck Rides Keytruda To Another Beat-And-Raise, But Diabetes Headwinds Persist
April 25, 2024
Merck's bread-and-butter cancer drug grew by double digits again in the first quarter.
Via
Investor's Business Daily
Merck Announces First-Quarter 2024 Financial Results
April 25, 2024
From
Merck & Co., Inc.
Via
Business Wire
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
April 25, 2024
The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META)
Via
Benzinga
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
April 24, 2024
Immutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line treatment of HNSCC patients without PD-L1 expression. Final data expected in H1 CY2024.
Via
Benzinga
Investor Alert: Prepare for the Market Crash With These 3 Stocks
April 23, 2024
These are the low-beta and attractively valued stocks to buy for a market crash as they represent companies with strong fundamentals.
Via
InvestorPlace
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
April 23, 2024
These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.
Via
InvestorPlace
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.